Supply shortage · 24.06.2026
Supply shortage: Synarela 200 Mikrogramm/Dosis Nasenspray
Affected country: Denmark · Reported period: Mid-May 2026 – End of August 2026 · Active ingredient: Nafarelin (Nafarelinacetat)
Notice context
A supply shortage has been recorded for Synarela 200 Mikrogramm/Dosis Nasenspray in Denmark. The stated reason is “Production problems”. The notice concerns the active ingredient Nafarelin (Nafarelinacetat) and is not identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Official shortage notice for Denmark. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →